Coronavirus live updates: Delhi reports highest single-day spike of 3,137 Covid cases

Telangana records highest single-day spike of 499 Covid positive cases: ANI

Telangana recorded the highest single-day spike of 499 positive cases of COVID-19 on Friday, as per information provided by the State government. Out of the total cases, 329 cases were reported from Greater Hyderabad Municipal Corporation (GHMC), 129 cases were reported from Ranga Reddy, seven were reported from Jangaon, six from Mahabubnagar.

Delhi reports highest single-day spike of 3,137 Covid-19 cases, reports ANI

Delhi on Friday reported the highest single-day spike of 3,137 new positive cases, taking the total number of COVID-19 cases in the national capital to 53,116. As many as 66 deaths were reported in the last 24 hours, taking the toll to 2,035.

Brazil now has more than 1 million coronavirus cases, reports Reuters

Brazil has recorded 1,032,913 confirmed cases, second only to the United States, with 1,206 new deaths reported on Friday to take the total official fatalities to 48,954, the ministry said.

1,269 new coronavirus cases in Mumbai, 114 deaths: PTI

The tally of coronavirus cases in Mumbai rose to 64,068 with 1,269 new patients detected on Friday while the death toll due to the pandemic reached 3,423 with 114 deaths, said BMC

LG's decision on home isolation will discourage many people from getting tested and spread coronavirus further: Delhi govt

Pune district administration registers FIR against a 31-year-old man for refusing to go into institutional quarantine on his return from abroad, reports ANI.

217 new Covid-19 cases reported in the state today, taking the total number of positive cases to 3,832, including 1,104 active cases and 92 deaths: Punjab health department

With 11 Covid-19 fatalities in West Bengal, death toll reaches 529; 355 new cases push tally to 13,090, reports PTI.

Lockdown provided 'breathing space' to ramp up testing, health infrastructure, says government.

Nashik city crossed 1,000-mark of Covid-19 patients

Seventy five more were tested positive on Friday taking tally of Covid-19 patients to 1,052 with total of 51 deaths.

112 more Covid-19 positive cases in Bihar taking the total to 7,290

Today, 12,680 people in Delhi were tested for Covid-19 using 'Rapid Antigen Testing' Kit, out of which 951 people were found positive: Delhi deputy CM Manish Sisodia

Read: Glenmark gets DCGI nod for favipiravir for treatment of Covid patients

Drug firm Glenmark Pharmaceuticals on Friday said it has received approval from the Indian drug regulator to launch oral antiviral drug favipiravir for treatment of mild to moderate COVID-19 patients in the country. It is for restricted emergency use in India. Restricted use entails responsible medication use where every patient must have signed informed consent before treatment initiation, Glenmark Pharmaceuticals said in a statement.

Anti-viral drug favipiravir gets nod for restricted emergency use in mild to moderate Covid-19 cases, reports PTI.

"The drug has been approved for restricted emergency use in the country for the treatment of mild to moderate cases of Covid-19," an official source in the know of developments told PTI. Following this approval, Mumbai-headquartered Glenmark Pharmaceuticals will make a separate application to state regulators to get a manufacturing license under the provisions of the Drugs and Cosmetics Act and its rules.

Director-General of ICMR Dr Balram Bhargava has directed all States to ramp up testing for Covid-19 in containment zones and hospitals, reports ANI.

Read: HCQ exports ban lifted after ensuring surplus stock in domestic market, says government

During March-May 2020, the number of manufacturing units of hydroxychloroquine increased from 2 to 12 and the country's production capacity of hydroxychloroquine rose from around 10 crore tablets per month to around 30 crore tablets per month. "Currently, India is having a surplus of hydroxychloroquine tablets over and above its domestic requirements," it said adding that the ministry of health and family welfare (MoHFW) is maintaining enough buffer stock of HCQ to cater to domestic demand, it said.

Read: Niti Aayog forms panel to develop job platform for migrant labours

"Niti Aayog under the leadership of its CEO, Amitabh Kant has formed a high-powered committee to drive public and private partnership in order to engage and develop technologies that can solve this looming crisis and provide better job opportunities to the migrant workers," the source said.